T
Tivic Health Systems, Inc. (TIVC)
NCM – Real Time Price. Currency in USD
1.40
+1.40 (0.00%)
At close: Apr 27, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.40
+1.40 (0.00%)
At close: Apr 27, 2026, 4:00 PM EDT
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in Fremont, California.
| Name | Position |
|---|---|
| Mr. Michael Kevin Handley | CEO & Director |
| Ms. Lisa G. Wolf | CFO and Principal Financial & Principal Accounting Officer |
| Date | Type | Document |
|---|---|---|
| 2026-04-23 | 8-K | tivic_8k.htm |
| 2026-04-20 | PRE 14A | tivic_pre14a.htm |
| 2026-04-13 | S-1 | tivic_s1.htm |
| 2026-04-06 | DRS | filename1.htm |
| 2026-03-30 | 10-K | tivc20251231_10k.htm |
| 2026-03-25 | 8-K | tivc20251119_8k.htm |
| 2026-03-20 | 8-K | tivic_8k.htm |
| 2026-03-13 | 8-K | tivic_8k.htm |
| 2026-03-11 | 8-K | tivic_8k.htm |
| 2026-03-04 | 8-K | tivic_8k.htm |